Pandemic policy interventions, such as the timing of vaccine boosters, take into account the length and efficiency of protection from infection with and immunization against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The threshold for preventing a symptomatic SARS-CoV-2 infection may be lower than the threshold for preventing all infections. Vaccination has been demonstrated to provide longer-lasting protection against hospitalization and mortality than it does against symptomatic and asymptomatic illness, according to recent studies.
President Heart Care Foundation of India and Group Editor in Chief MEDtalks
Recipient of Padma Shri, Vishwa Hindi Samman, National Science Communication Award and Dr B C Roy National Award, Dr Aggarwal is a physician, cardiologist, spiritual writer and motivational speaker. He was the Past President of the Indian Medical Association and President of Heart Care Foundation of India. He was also the Editor in Chief of the IJCP Group, Medtalks and eMediNexus
Adviser & Mentor for Centre of Excellence- Microbiology and leads knowledge forum at Pathkind Labs
Prof. Ashok Rattan is MD, MAMS, INSA DFG, WHO TA (SEARO),WHO Lab Director (CAREC/PAHO) a medical microbiologist by profession. He is at present Adviser & Mentor for Centre ofExcellence- Microbiology and leads knowledge forum at Pathkind Labs. He has also received A.P.J. Abdul Kalam Life time Achievement Award for his contribution to healthcare industry.